Why are you looking at Biocartis Us?
Capability
Service linesSURGICAL APPLIANCE AND SUPPLIES MANUFACTURING · IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING · ANALYTICAL LABORATORY INSTRUMENT MANUFACTURING
Work mix: 100% prime · 0% sub · primary NAICS 325413 / PSC 6550 IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS
Where they win
Sole agencyRecompete exposure: None
No incumbent recompetes detected in the next 24 months.
Agency buyer map
1 buyersRecompete exposure
NoneNo incumbent recompetes detected in the next 24 months.
No incumbent recompetes detected in the next 24 months.
GET THE FULL BRIEF
Get Biocartis Us’s recompete exposure, top agencies and teaming history
The outlook above is free to read and verify — an estimated $353K in play. Enter a work email for two figures the page cannot show.
“With competitive federal procurements, winning starts with strategically understanding the customer environment to the left of SAM.gov. This is what SCOUT does - a deeper and more precise understanding of what the…”
Enter your company name and we'll build the page.
Query this company live in SCOUT via MCP — personalized displacement scoring, alerts, and capture workflow. Learn about SCOUT MCP →
Frequently asked questions
What federal contracts does Biocartis Us hold?
Biocartis Us (UEI RY27EUE8U9B7) shows $353K across 9 award actions in SCOUT’s public USASpending-backed profile, with Department of Veterans Affairs (VA) as the top buying agency. Totals cover federal prime awards ≥$100K in the rolling window.
Which agencies does Biocartis Us work with?
Biocartis Us’s firm-wide obligated mix is led by Department of Veterans Affairs (VA) (100%).
Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows. Explore it live — $90 Pilot →